October 20, 2015
WILSON THERAPEUTICS APPOINTS ANDREW KAY AS CHAIRMAN
Media
October 16, 2015
Strongbridge Biopharma plc Announces Pricing of Its Initial U.S. Public Offering
October 15, 2015
Nordic Nanovector adapts clinical development plan for Betalutin® in Follicular Lymphoma
October 08, 2015
Nexstim Plc Supports 7th International Symposium on Navigated Brain Stimulation in Neurosurgery
September 30, 2015
Appointment of Mr. Andrew Kay to HealthCap Senior Advisor
September 30, 2015
Appointment of Mr. Andrew Kay to HealthCap Senior Advisor
September 26, 2015
Data Safety Monitoring Board Recommends Continuation of Nexstim Plc’s Phase III Stroke Therapy Trial
September 24, 2015
CERAMENT™ Antibiotic Eluting Bone Substitutes For The Management Of Osteomyelitis Prominent At The 34th Annual Meeting Of The European Bone & Joint Infection Society (EBJIS)
September 18, 2015
New regulations will expand access to treatment of opioid dependence in the US
September 17, 2015
SAVE THE DATE: NORDIC NANOVECTOR TO HOST CAPITAL MARKETS DAY IN OSLO, NORWAY ON 17 NOVEMBER 2015
